Skip to main content
. 2020 Jan 7;19(3):1831–1841. doi: 10.3892/ol.2020.11253

Figure 3.

Figure 3.

Differences in the prognostic values of RPA expression levels in male and female patients. Kaplan-Meier survival plots of patients with GC divided into those with high- and low-expression levels of RPA family members. (A) RPA2 (Affymetrix ID: 201756_at) in males; high-(n=109) vs. low-expression group (n=251). (B) RPA3 (Affymetrix ID: 209507_at) in males; high-(n=165) vs. low-expression group (n=195). (C) RPA4 (Affymetrix ID: 221143_at) in males; high-(n=91) vs. low-expression group (n=269). (D) RPA3 (Affymetrix ID: 209507_at) in females; high-(n=46) vs. low-expression group (n=92). (E) RPA4 (Affymetrix ID: 221143_at) in females, high-(n=54) vs. low-expression group (n=84). GC, gastric cancer; RPA, replication protein A; HR, hazard ratio.